Table 1 List of nanomedicines for cancer therapy approved by FDA [156,157,158,159]
From: Nanoparticles for Cancer Therapy: Current Progress and Challenges
| Tradename | Material | Drug | Company | Indication | Year(s) approved |
|---|---|---|---|---|---|
| Doxil® | Liposome-PEG | Doxorubicin | Janssen | MBC, metastatic ovarian cancer | 1995 |
| Eligard® | PLGA | Leuprolide acetate | Tolmar | Prostate Cancer | 2002 |
| Abraxane® | Albumin | Paclitaxel | Celgene | Metastatic breast cancer | 2005 |
| Genexol PM® | mPEG-PLA | Paclitaxel | Samyang Corporation | Metastatic breast cancer | 2007 |
| Onivyde® | Liposome | Irinotecan | Merrimack | Pancreatic cancer | 2015 |